Cargando…

Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer

Prostate cancer is the most common cancer in men, and it is primarily driven by androgen steroid hormones. The glycosylation enzyme EDEM3 is controlled by androgen signalling and is important for prostate cancer viability. EDEM3 is a mannosidase that trims mannose from mis-folded glycoproteins, tagg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Emma, Garnham, Rebecca, Cheung, Kathleen, Duxfield, Adam, Elliott, David J., Munkley, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332126/ https://www.ncbi.nlm.nih.gov/pubmed/35897761 http://dx.doi.org/10.3390/ijms23158184

Ejemplares similares

Mannosidase activity of EDEM1 and EDEM2 depends on an unfolded state of their glycoprotein substrates
por: Shenkman, Marina, et al.
Publicado: (2018)

Hydrophobicity of protein determinants influences the recognition of substrates by EDEM1 and EDEM2 in human cells
por: Sokołowska, Iwona, et al.
Publicado: (2015)

ST6GAL1: A key player in cancer
por: Garnham, Rebecca, et al.
Publicado: (2019)

Glycans as Biomarkers in Prostate Cancer
por: Scott, Emma, et al.
Publicado: (2019)

Purified EDEM3 or EDEM1 alone produces determinant oligosaccharide structures from M8B in mammalian glycoprotein ERAD
por: George, Ginto, et al.
Publicado: (2021)

Targeting EDEM protects against ER stress and improves development and survival in C. elegans
por: Ghenea, Simona, et al.
Publicado: (2022)

Comparison of Cohesive Models in EDEM and LIGGGHTS for Simulating Powder Compaction
por: Ramírez-Aragón, Cristina, et al.
Publicado: (2018)

Role of Drosophila EDEMs in the degradation of the alpha-1-antitrypsin Z variant
por: JANG, BO-YUN, et al.
Publicado: (2015)

EDEM3 Domains Cooperate to Perform Its Overall Cell Functioning
por: Manica, Georgiana, et al.
Publicado: (2021)

Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer
por: Advani, Rahul, et al.
Publicado: (2023)

Bypass of glycan-dependent glycoprotein delivery to ERAD by up-regulated EDEM1
por: Ron, Efrat, et al.
Publicado: (2011)

Tyrosinase Degradation Is Prevented when EDEM1 Lacks the Intrinsically Disordered Region
por: Marin, Marioara B., et al.
Publicado: (2012)

Dataset of human EDEM2 melanoma cells proteomics, affinity proteomics and deglycoproteomics
por: Chirițoiu, Gabriela N., et al.
Publicado: (2021)

CRELD2 is a novel modulator of calcium release and calcineurin-NFAT signalling during osteoclast differentiation
por: Duxfield, Adam, et al.
Publicado: (2022)

EDEM2 initiates mammalian glycoprotein ERAD by catalyzing the first mannose trimming step
por: Ninagawa, Satoshi, et al.
Publicado: (2014)

Edem1 activity in the fat body regulates insulin signalling and metabolic homeostasis in Drosophila
por: Pathak, Himani, et al.
Publicado: (2021)

EDEM1 Regulates Amyloid Precursor Protein (APP) Metabolism and Amyloid-β Production
por: Nowakowska-Gołacka, Jowita, et al.
Publicado: (2021)

Numerical simulation and parameter optimization of earth auger in hilly area using EDEM software
por: Wang, Guofu, et al.
Publicado: (2022)

RNA splicing and splicing regulator changes in prostate cancer pathology
por: Munkley, Jennifer, et al.
Publicado: (2017)

The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer
por: Hodgson, Kirsty, et al.
Publicado: (2023)

Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment
por: Hosseini-Beheshti, Elham, et al.
Publicado: (2016)

FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer
por: Bastian, Kayla, et al.
Publicado: (2021)

EDEM2 and OS-9 Are Required for ER-Associated Degradation of Non-Glycosylated Sonic Hedgehog
por: Tang, Hsiang-Yun, et al.
Publicado: (2014)

EDEM3 Modulates Plasma Triglyceride Level through Its Regulation of LRP1 Expression
por: Xu, Yu-Xin, et al.
Publicado: (2020)

Affinity Proteomics and Deglycoproteomics Uncover Novel EDEM2 Endogenous Substrates and an Integrative ERAD Network
por: Munteanu, Cristian V.A., et al.
Publicado: (2021)

Targeting Aberrant Sialylation to Treat Cancer
por: Munkley, Jennifer, et al.
Publicado: (2019)

EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis
por: Wu, Yuxi, et al.
Publicado: (2023)

Prostate cancer bone metastases biology and clinical management (Review)
por: Archer Goode, Emily, et al.
Publicado: (2023)

EDEM2 stably disulfide-bonded to TXNDC11 catalyzes the first mannose trimming step in mammalian glycoprotein ERAD
por: George, Ginto, et al.
Publicado: (2020)

Hallmarks of glycosylation in cancer
por: Munkley, Jennifer, et al.
Publicado: (2016)

Identification of EGF Receptor and Thrombospondin-1 as Endogenous Targets of ER-Associated Degradation Enhancer EDEM1 in HeLa Cells
por: Miura, Kohta, et al.
Publicado: (2023)

CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer
por: Alebady, Zainab A. H., et al.
Publicado: (2023)

EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired
por: Chiritoiu, Marioara, et al.
Publicado: (2020)

A Predominant Role of AtEDEM1 in Catalyzing a Rate-Limiting Demannosylation Step of an Arabidopsis Endoplasmic Reticulum-Associated Degradation Process
por: Zhang, Jianjun, et al.
Publicado: (2022)

EDEM1 regulates the insulin mRNA level by inhibiting the endoplasmic reticulum stress-induced IRE1/JNK/c-Jun pathway
por: (Flintoaca) Alexandru, Petruta R., et al.
Publicado: (2023)

Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells
por: Munkley, Jennifer, et al.
Publicado: (2015)

Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients
por: EL-SAGHIRE, HOUSSEIN, et al.
Publicado: (2014)

The Role of Sialyl-Tn in Cancer
por: Munkley, Jennifer
Publicado: (2016)

The glycosylation landscape of pancreatic cancer
por: Munkley, Jennifer
Publicado: (2019)

Aberrant Sialylation in Cancer: Therapeutic Opportunities
por: Munkley, Jennifer
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m4joeitni24r3sq5ku5ank68r2